Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
30 11 2020
30 11 2020
Historique:
received:
22
07
2020
accepted:
13
11
2020
entrez:
1
12
2020
pubmed:
2
12
2020
medline:
12
3
2021
Statut:
epublish
Résumé
Giant cell arteritis (GCA, also called temporal arteritis) is a rare and Takayasu arteritis (TA) is an even rarer autoimmune disease (AID), both of which present with inflammatory vasculitis of large and medium size arteries. The risk factors are largely undefined but disease susceptibility has been associated with human leukocyte antigen locus. Population-level familial risk is not known. In the present nation-wide study we describe familial risk for GCA and for GCA and TA with any other AID based on the Swedish hospital diagnoses up to years 2012. Family relationships were obtained from the Multigeneration Register. Familial standardized incidence ratios (SIRs) were calculated for offspring whose parents or siblings were diagnosed with GCA, TA or any other AID. The number of GCA patients in the offspring generation was 4695, compared to 209 TA patients; for both, familial patients accounted for 1% of all patients. The familial risk for GCA was 2.14, 2.40 for women and non-significant for men. GCA was associated with 10 other AIDs and TA was associated with 6 other AIDs; both shared associations with polymyalgia rheumatica and rheumatoid arthritis. The results showed that family history is a risk factor for GCA. Significant familial associations of both GCA and TA with such a number of other AIDs provide evidence for polyautoimmunity among these diseases.
Identifiants
pubmed: 33257751
doi: 10.1038/s41598-020-77857-7
pii: 10.1038/s41598-020-77857-7
pmc: PMC7705754
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
20887Références
Nat Med. 2015 Sep;21(9):1018-27
pubmed: 26301688
PLoS Genet. 2011 Dec;7(12):e1002406
pubmed: 22174698
Int J Cancer. 2010 May 15;126(10):2259-67
pubmed: 19642094
Br Med Bull. 1961 Sep;17:251-4
pubmed: 13691133
Arthritis Rheumatol. 2015 May;67(8):2226-32
pubmed: 25931203
Autoimmun Rev. 2012 Aug;11(10):754-65
pubmed: 22387972
Leukemia. 2016 Aug;30(8):1766-9
pubmed: 26975726
Am J Hum Genet. 2016 Jul 7;99(1):22-39
pubmed: 27346689
Br J Dermatol. 2020 Sep;183(3):488-494
pubmed: 31853941
Vasc Med. 2019 Feb;24(1):79-88
pubmed: 30355272
Lancet. 2013 Jan 5;381(9860):63-72
pubmed: 23051717
Int J Angiol. 2019 Dec;28(4):215-225
pubmed: 31787819
J Transl Autoimmun. 2020 Jun 01;3:100058
pubmed: 32743538
Endocrinol Metab (Seoul). 2018 Jun;33(2):175-184
pubmed: 29947174